期刊文献+

细胞自噬在儿童急性B淋巴细胞白血病化疗抵抗中的作用 被引量:2

Role of cellular autophagy in chemotherapy resistance of children with B-cell acute lymphocytic leukemia
下载PDF
导出
摘要 目的以长春新碱(VCR)处理的人急性B淋巴细胞白血病细胞(BLCs)为模型,研究细胞自噬在儿童急性B淋巴细胞白血病(B-ALL)化疗中的作用。方法将BLCs随机分为对照组、药物组、阻断组和联合组,分别加入等体积的PBS、1μg/m L的VCR、10 mmol/L的细胞自噬抑制剂3-甲基腺嘌呤(3-MA)、1μg/m L的VCR+10mmol/L的3-MA处理48 h,采用WST-1法测算细胞增殖抑制率,免疫印迹法检测自噬相关蛋白轻链3β(LC3β)。结果处理细胞48 h后,药物组、阻断组和联合组细胞增殖抑制率分别为9.7%±3.3%、63.4%±9.1%、80.6%±8.3%;各组间两两比较,P均<0.01。对照组、药物组、阻断组和联合组LC3β蛋白表达量分别为0.02±0.01、0.31±0.05、0.01±0.01、0.02±0.01,药物组高于其他组(P均<0.01),其余各组间比较无统计学意义。结论细胞自噬可在ALL化疗过程中活化导致化疗抵抗。 Objective We take the human B-cell acute lymphocytic leukemia cells( BLCs) treated with vincristine( VCR) as the models to investigate the role of cellular autophagy in chemotherapy resistance of childhood B-cell acute lymphoblastic leukemia( B-ALL). Methods BLCs were randomly divided into the control group,experimental group,blocker group and union group,which were respectively treated with the same volume of PBS,1 μg / m L VCR,10 mmol / L 3-methyladenine( 3-MA) and 1 μg / m L VCR + 10 mmol / L 3-MA for 48 h. Transmission electron microscope was used to detect the autophagosome,WST-1 was employed to calculate the proliferation inhibitory rate and Western blotting was performed to detect the autophagy-related protein light chain 3β( LC3β) expression. Results The inhibition rates after 48 h treatment in the experimental group,blocker group and union group were 9. 7% ± 3. 3%,63. 4% ± 9. 1% and 80. 6% ± 8. 3%,respectively( all P 〈0. 01). The LC3β expression in the control group,experimental group,blocker group and union group was 0. 02 ± 0. 01,0. 31 ± 0. 05,0. 01 ± 0. 01 and 0. 02 ± 0. 01,respectively,and the experimental group was higher than the other groups( all P 〈0. 01),no significant difference was found among the other three groups. Conclusion Autophagy can be activated during chemotherapy of ALL,leading to chemotherapy resistance.
出处 《山东医药》 CAS 北大核心 2016年第10期20-22,共3页 Shandong Medical Journal
基金 河南省教育厅自然科学基金项目(13A310843) 新乡医学院重点研究领域招标课题项目(ZD2011-12)
关键词 急性淋巴细胞白血病 细胞自噬 自噬相关蛋白轻链3β 化学疗法 耐药 3-甲基腺嘌呤 儿童 acute lymphoblastic leukemia autophagy autophagy-related protein light chain 3β chemotherapy drug-resistance 3-methyladenine child hood
  • 相关文献

参考文献13

  • 1Deretic V.Autophagy in immunity and cell-autonomous defense against intracellular microbes[J].Immunol Rev,2013,240(1):92-104.
  • 2Arsov I,Adebayo A,Kucerova-Levisohn M,et al.A role for autophagic protein beclin 1 early in lymphocyte development[J].J Immunol,2015,186(4):2201-2209.
  • 3Grandér D,Panaretakis T.Autophagy:cancer therapy's friend or foe[J].Future Med Chem,2010,2(2):285-297.
  • 4NíCheallaigh C,Keane J,Lavelle EC,et al.Autophagy in the immune response to tuberculosis:clinical perspectives[J].Clin Exp Immunol,2013,164(3):291-300.
  • 5Rao DN,Anuradha C,Vishnupriya S,et al.Association of an MDR1 gene(C3435T)polymorphism with acute leukemia in India[J].Asian Pac J Cancer Prev,2014,11(4):1063-1066.
  • 6Tang D,Kang R,Cheh CW,et al.HMGB1 release and redox regulates autophagy and apoptosis in cancer cells[J].Oncogene,2013,29(38):5299-5310.
  • 7Shpilka T,Weidberg H,Pietrokovski S,et al.Atg8:an autophagy-related ubiquitin-like protein family[J].Genome Biol,2011,12(7):226.
  • 8Kang R,Livesey KM,Zeh HJ 3rd,et al.HMGB1 as an autophagy sensor in oxidative stress[J].Autophagy,2011,7(8):904-906.
  • 9Wu YT,Tan HL,Shui G,et al.Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase[J].J Biol Chem,2014,285(14):10850-10861.
  • 10张志向,柴忆欢,何海龙,王易,胡绍燕,赵文理,李建琴,卢俊,肖佩芳,季正华,计雪强.急性淋巴细胞白血病患儿骨髓微小残留病检测的临床意义[J].实用儿科临床杂志,2010,25(15):1133-1135. 被引量:10

二级参考文献16

  • 1Faded S, Kantarjian HM, Talpaz M, et al. Clinical significance of minireal residual disease in leukemia [ J ]. lnt J Oncol,2000,17 (6) : 1277 - 1287.
  • 2Campana D. Minimal residual disease studies in acute leukemia[ J]. Am J Clin Pathol,2004,122 (suppl) :47 - 57.
  • 3Pui CH, Campana D. New definition of remission in childhood acute lymphoblastie leukemia [ J ]. Leukemia ,2000,14 (5) :783 - 785.
  • 4Nyvold C, Madsen HO, Ryder LP, et al. Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome [ J ]. Blood, 2002,99 (4) :1253 - 1258.
  • 5Coustan - Smith E, Sancho J, Hancock ML, et al. Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia [ J ]. Blood, 2000,96 ( 8 ) : 2691 - 2696.
  • 6Borowitz MJ,Devidas M,Hunger SP,et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors. A Children's Oncology Group study[ J]. Blood,2008,111 (12) :5477 -5485.
  • 7Campana D. Minimal residual disease in aetue lymphoblastic leukemia [J]. Semin Hematol,2009,46( l ) :100 - 106.
  • 8Flohr T, Schrauder A, Cazzaniga G, et al. Minimal residual disease - di- rected risk stratification using real - time quantitative PCR analysis of immunoglobulin and T - cell receptor gene re~gements in the international multicenter trial AIEOP - BFM ALL 2000 for childhood acute lymphoblastic leukemia [ J ]. Leukemia, 2008,22 ( 4 ) : 771 - 782.
  • 9Holowiecki J, Krawczyk - Kulis M, Giebel S, et al. Status of minimal residual disease after induction predicts outcome in both standard and high - risk Ph - negative adult acute lymphoblastic leukemia. The Polish Adult Leukemia Group ALL4 - 2002 MRD Study [ J ]. British J Haematol,2008,142 (2) :227 - 237.
  • 10Schrappe M. Evolution of BFM trials for childhood ALL [ J ]. Ann Hematol,2004,83 (suppl 1 ) :121 - 123.

共引文献9

同被引文献23

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部